<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Coronary collateral circulation</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Coronary collateral circulation</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Coronary collateral circulation</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bruce D Klugherz, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel M Kolansky, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Todd F Dardas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 09, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>This topic will discuss aspects of coronary artery collateral vessels, including their potential role in minimizing myocardial ischemia. The broader discussion on the management of myocardial ischemia is found elsewhere. (See  <a class="medical medical_review" href="/z/d/html/1488.html" rel="external">"Silent myocardial ischemia: Epidemiology, diagnosis, treatment, and prognosis"</a> and  <a class="medical medical_review" href="/z/d/html/1472.html" rel="external">"Approach to the patient with suspected angina pectoris"</a>.)</p><p class="headingAnchor" id="H2987276178"><span class="h1">DEFINITIONS</span><span class="headingEndMark"> — </span>Anastomotic channels, known as collateral vessels, can develop in the heart as an adaptation to ischemia [<a href="#rid1">1,2</a>]. They serve as conduits that bridge severe stenoses or connect a territory supplied by one epicardial coronary artery with that of another [<a href="#rid3">3</a>]. Collaterals therefore provide an alternative source of blood supply to myocardium jeopardized by occlusive coronary artery disease, and they can help to preserve myocardial function in the setting of a chronic total coronary occlusion [<a href="#rid4">4</a>].</p><p>Two classes of collateral vessels have been recognized:</p><p class="bulletIndent1"><span class="glyph">●</span>Capillary size collaterals, in which smooth muscle cells are absent, may be observed throughout the myocardium, although they have a predilection for the subendocardium.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Larger, muscular collaterals, which develop from pre-existing arterioles, are typically located epicardially [<a href="#rid5">5</a>].</p><p></p><p class="headingAnchor" id="H2"><span class="h1">DETERMINANTS OF RECRUITMENT</span><span class="headingEndMark"> — </span>The clinical and pathophysiologic determinants of collateral recruitment are poorly understood. Although primarily thought to be initiated by ischemia, appreciable collateral perfusion is present in some patients who do not have coronary disease [<a href="#rid6">6</a>].</p><p>Studies of transient coronary occlusion during balloon angioplasty have found that the following independent clinical and angiographic variables are correlated with increases in collateral flow [<a href="#rid4">4,7-9</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Longer duration of angina</p><p class="bulletIndent1"><span class="glyph">●</span>Greater level of long-term physical activity during leisure time</p><p class="bulletIndent1"><span class="glyph">●</span>Greater lesion severity</p><p class="bulletIndent1"><span class="glyph">●</span>Proximal lesion location</p><p class="bulletIndent1"><span class="glyph">●</span>Greater duration of lesion occlusion</p><p></p><p>Collateral recruitment may be diminished in older adults. In a study of over 1900 patients undergoing angiography within 72 hours after an acute myocardial infarction (MI), the prevalence of collaterals was 48 percent in patients &lt;50 years of age and only 34 percent in patients ≥70 years of age [<a href="#rid10">10</a>]. </p><p class="headingAnchor" id="H1537238839"><span class="h2">Role of diabetes</span><span class="headingEndMark"> — </span>Patients with coronary artery disease who have diabetes mellitus have a less favorable outcome than those without diabetes. In addition, they have a higher mortality and are more likely to experience a complication after MI, such as post-infarction angina or congestive heart failure. (See  <a class="medical medical_review" href="/z/d/html/1581.html" rel="external">"Coronary artery revascularization in stable patients with diabetes mellitus"</a> and  <a class="medical medical_review" href="/z/d/html/84.html" rel="external">"Acute myocardial infarction: Patients with diabetes mellitus"</a>.)</p><p>The less favorable outcomes among patients with diabetes may be attributable to fewer collaterals. One study of 306 patients with diabetes who underwent coronary angiography found that these patients had a lower mean collateral score compared with nondiabetics (2.4 versus 2.6), suggesting that patients with diabetes may have poorer development of collaterals [<a href="#rid11">11</a>]. Fewer collaterals were also observed among patients with type 2 diabetes in a contemporary study of percutaneous coronary intervention (PCI) performed for chronic total occlusion [<a href="#rid12">12</a>].</p><p class="headingAnchor" id="H3"><span class="h2">Role of cytokines</span><span class="headingEndMark"> — </span>The underlying mechanisms by which ischemia induces collateral vessel formation are unknown. Several endothelial and smooth muscle cell mitogens have been implicated [<a href="#rid13">13-16</a>]. As an example, markedly elevated levels of basic fibroblast growth factor (bFGF) have been demonstrated in the pericardial fluid of patients undergoing coronary artery bypass grafting for unstable angina [<a href="#rid13">13</a>]. In patients with coronary disease undergoing angioplasty, intracoronary concentrations of bFGF and vascular endothelial growth factor (VEGF) are associated with a directly-measured index of collateral flow; the concentration of VEGF is influenced by the degree of coronary atherosclerosis [<a href="#rid17">17</a>]. In addition, increased expression of VEGF has been shown in animal models of acute myocardial ischemia [<a href="#rid14">14</a>] and in patients with an acute MI; levels are higher in those with, compared to those without, improvement of left ventricular function [<a href="#rid18">18</a>]. VEGF induces or stimulates collateral vessel formation and improves the impaired endothelium-dependent relaxation of collaterals [<a href="#rid19">19</a>]; the induction of coronary collateralization by VEGF requires the production of nitric oxide, which is an important regulator of collateral growth [<a href="#rid20">20</a>]. Newer studies continue to implicate new molecular signals possibly involved in coronary arteriogenesis, and this is an active area of investigation [<a href="#rid15">15,16</a>].</p><p>Although suggestive, these studies do not directly prove a causative role for these molecules in the induction of collateral vasculogenesis. </p><p class="headingAnchor" id="H4"><span class="h1">PHYSIOLOGY</span><span class="headingEndMark"> — </span>In a canine model of collateral development, gradual occlusion of an epicardial coronary artery resulted in collateral vessel growth sufficient to provide approximately 80 percent of the blood flow to normally perfused myocardium [<a href="#rid21">21</a>]. Although collateral vessel blood flow after epicardial coronary occlusion may be adequate to meet myocardial needs at rest, collateral circulation is generally <strong>not</strong> sufficient to meet myocardial demands during exercise [<a href="#rid22">22</a>] and may not prevent myocardial ischemia during coronary occlusion. This was illustrated by one study of 450 patients, which found that 67 percent did not have enough collateral flow to prevent myocardial ischemia produced by balloon angioplasty [<a href="#rid9">9</a>].</p><p>Quantitative radionuclide myocardial perfusion imaging with positron emission tomography has added to the understanding of blood flow regulation in collateral circulation in humans. Applying this technique to patients with single vessel coronary occlusion, blood flow to collateral-dependent myocardium was shown to increase by nearly 35 percent during atrial pacing-induced tachycardia, a condition that increases myocardial oxygen demand [<a href="#rid23">23</a>]. This degree of flow augmentation, however, was far less than that observed among normal controls. This method is not typically used for diagnostic assessment.</p><p>Endothelial release of nitric oxide [<a href="#rid24">24</a>] and activation of beta-adrenergic receptors, whose existence has been demonstrated in collateral vasculature [<a href="#rid25">25</a>], may be responsible for vasodilation of coronary collaterals. In contrast, alpha-adrenergic receptors have not been identified in isolated rings of collateral tissue [<a href="#rid26">26</a>].</p><p>Studies in animal models have shown that beta blockers induce vasoconstriction of coronary collaterals during exercise, thereby reducing collateral blood flow [<a href="#rid27">27</a>]. A similar effect can be induced by inhibitors of nitric oxide synthesis [<a href="#rid28">28</a>] and by a platelet activating factor that causes platelet aggregation and the release of the potent vasoconstrictors thromboxane A2 and serotonin [<a href="#rid29">29</a>]. These observations may have clinical implications in patients with collateral-dependent myocardium, especially during episodes of ischemia and subsequent platelet activation.</p><p class="headingAnchor" id="H3158633880"><span class="h2">Changes in collateral vessel function over time</span><span class="headingEndMark"> — </span>Increased antegrade flow through a collateralized coronary artery following successful percutaneous coronary intervention results in gradual regression of collateral function. In a study of 103 patients who underwent successful recanalization of chronically occluded coronary arteries, coronary pressure-derived collateral function dropped by 23 percent immediately following the intervention, and by another 23 percent during median five-month follow-up [<a href="#rid30">30</a>]. In this study, recruitable coronary collateral flow was best preserved among patients with larger collaterals. </p><p>One study compared temporal changes in coronary collateral function following coronary recanalization among 23 patients with acute occlusions and 74 patients with chronic occlusions [<a href="#rid31">31</a>].<sup> </sup>Notably, recruitable coronary collateral flow was greater in successfully recanalized chronically occluded coronaries compared with acutely occluded coronaries. Furthermore, among patients who received successful recanalization of chronically (but not acutely) occluded coronaries, those who had greater collateral recruitability (as determined by the collateral pressure index) had fewer adverse cardiac events during the follow-up period. </p><p>Another study demonstrated that collateral recruitment as measured by coronary flow index improved in patients with stable coronary artery disease following four weeks of moderate or intense exercise [<a href="#rid32">32</a>].</p><p>These studies provide further evidence of a correlation between collateral vessel function and long-term clinical outcomes. </p><p class="headingAnchor" id="H5"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>Coronary collaterals have been traditionally identified and assessed using selective coronary angiography; this technique offers direct visualization of collateral vessels exceeding 100 microns in diameter [<a href="#rid33">33,34</a>]. A classification system for collateral flow from patent vessels to the occluded vessel was developed by Rentrop [<a href="#rid35">35</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Grade 0</strong> – No visible filling of any collateral channel</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Grade 1</strong> – Filling of the side branches of the occluded artery, with no dye reaching the epicardial segment</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Grade 2</strong> – Partial filling of the epicardial vessel</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Grade 3</strong> – Complete filling of the epicardial vessel by collaterals</p><p></p><p>This relatively simple angiographic method remains the mainstay for identification of the presence and extent of coronary collaterals. </p><p>Quantification of the extent of collateral flow can be performed by a number of methods, as described below. While of interest physiologically, the practical application of these methods in clinical care is not often done. </p><p>Intracoronary flow velocity, flow capacity, or pressure measurements obtained during routine catheterization and angioplasty can provide an accurate and quantitative method for assessing the collateral circulation, although these are not commonly used clinically [<a href="#rid34">34,36</a>]. (See  <a class="medical medical_review" href="/z/d/html/1514.html" rel="external">"Clinical use of coronary artery pressure flow measurements"</a>.)</p><p>For patients undergoing percutaneous coronary intervention (PCI), the Doppler-derived or pressure-derived collateral flow index (CFI), which is defined as the ratio of flow during balloon inflation divided by resting flow, may be calculated. CFI is a useful measure for assessing the effects of various pharmacologic agents, such as <a class="drug drug_general" data-topicid="9359" href="/z/d/drug information/9359.html" rel="external">adenosine</a> and <a class="drug drug_general" data-topicid="9645" href="/z/d/drug information/9645.html" rel="external">metoprolol</a>, on coronary collateral perfusion [<a href="#rid37">37</a>]. Pressure-derived CFI was shown to predict left ventricular dilation one year following thrombolysis for acute MI [<a href="#rid38">38</a>].</p><p>Myocardial contrast echocardiography, which for this purpose involves the selective coronary injection of sonicated microbubbles, is an alternative diagnostic tool for the assessment of coronary collaterals. This technique may more precisely identify the spatial extent of perfusion via collateral vessels [<a href="#rid39">39</a>]. However, United States Food and Drug Administration (FDA) approved agents for cardiac imaging are contraindicated for intraarterial injection. (See  <a class="medical medical_review" href="/z/d/html/5301.html" rel="external">"Contrast echocardiography: Contrast agents, safety, and imaging technique"</a> and  <a class="medical medical_review" href="/z/d/html/5313.html" rel="external">"Contrast echocardiography: Clinical applications"</a>.)</p><p>Myocardial contrast echocardiography and angiography appear to differ in their ability to detect the functional significance of collateral beds [<a href="#rid33">33,40,41</a>]. Surprisingly, there is a poor correlation between the presence of well-visualized collaterals at angiography and the preservation of segmental wall motion in patients with chronically occluded epicardial coronary arteries [<a href="#rid33">33</a>]. By comparison, myocardial contrast echocardiography more reliably reflects wall motion in these patients, perhaps due to more precise delineation of microvascular perfusion [<a href="#rid40">40</a>].</p><p>Myocardial contrast echocardiography has also been used to predict functional recovery after revascularization of collateralized myocardium. In one series, for example, improvement in left ventricular function correlated with successful angioplasty of the infarct-related artery [<a href="#rid41">41</a>]. Among patients in whom angioplasty was successful, those with &gt;50 percent of the infarct bed perfused by collaterals, as demonstrated by myocardial contrast echocardiography, had superior baseline wall motion and wall motion one month following revascularization compared with those whose infarct beds were ≤50 percent perfused by collateral flow. This suggests that myocardial viability may be associated with the presence of collateral blood flow within the infarct bed.</p><p>Other noninvasive techniques can assess the collateral circulation. The severity of 99m-technetium-sestamibi tomographic perfusion defects, for example, has been shown to correlate closely with absolute collateral flow as measured by radiolabeled microspheres in animal models of coronary occlusion [<a href="#rid42">42</a>] and with collateral fractional flow reserve, an index of collateral flow in patients [<a href="#rid43">43</a>]. (See  <a class="medical medical_review" href="/z/d/html/1473.html" rel="external">"Assessment of myocardial viability by nuclear imaging in coronary heart disease"</a>.) Spiral computerized tomography (CT) [<a href="#rid44">44</a>], magnetic resonance imaging [<a href="#rid45">45</a>], and positron emission tomography [<a href="#rid23">23,46</a>] have also been validated and may ultimately prove clinically useful in the assessment of myocardial collateralization. (See  <a class="medical medical_review" href="/z/d/html/5314.html" rel="external">"Clinical utility of cardiovascular magnetic resonance imaging"</a>.)</p><p class="headingAnchor" id="H6"><span class="h1">CLINICAL SIGNIFICANCE</span><span class="headingEndMark"> — </span>In the setting of acute MI, thrombotic occlusion of an epicardial coronary artery results in downstream myonecrosis and cell death, with resultant segmental abnormalities of regional wall motion. More myocardial injury leads to greater decrease in left ventricular ejection fraction and a worse prognosis. Pre-existing collateral vessels have the potential to reduce the severity of injury by providing blood flow to the threatened segments. Indeed, this concept has been shown during brief episodes of coronary occlusion produced by angioplasty, where the presence of recruitable collaterals reduces the severity of regional myocardial hypoperfusion in some patients, as evaluated with radionuclide myocardial perfusion imaging [<a href="#rid47">47</a>].</p><p>Specific beneficial effects observed in the presence of collateral vessels include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reduced infarction size </strong>– In a canine model of electrically-induced left circumflex coronary thrombosis, infarct size as determined histochemically was smaller among dogs with contrast echo-detected collateral perfusion than among those without collaterals (4 versus 11 percent) [<a href="#rid48">48</a>]. In patients in the TIMI trial, infarct size, as determined by serum creatine kinase, was smaller among patients with collateral vessels compared to those without such vessels (20.6 versus 31.4 CK gram equivalents, p = 0.001) [<a href="#rid49">49</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Greater postinfarction ejection fraction</strong> – Smaller infarct size should translate into a greater postinfarction left ventricular ejection fraction (LVEF) [<a href="#rid50">50,51</a>]. One study found that, in patients with sufficient collaterals, left ventricular recovery after reperfused MI is primarily determined by the amount of collateral blood flow and is less dependent upon the time to reperfusion [<a href="#rid52">52</a>]. In one series of patients with occluded culprit arteries after fibrinolytic therapy, the presence of significant collateral flow (as determined angiographically) was associated with a significantly higher postinfarction LVEF (60 versus 54 percent for those with lesser collateral flow) [<a href="#rid51">51</a>]. Preservation of left ventricular function has also been observed following the late administration of fibrinolytic therapy to patients suffering from acute MI who had a collateralized infarct-related artery [<a href="#rid53">53</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reduced risk for rupture</strong> – The presence of collaterals may reduce the risk for rupture of papillary muscle, myocardial free wall, or interventricular septum. (See  <a class="medical medical_review" href="/z/d/html/63.html" rel="external">"Acute myocardial infarction: Mechanical complications"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Decreased aneurysmal dilatation</strong> – In one series of 47 patients given fibrinolytic therapy within six hours of a first MI, the incidence of left ventricular aneurysm was 4 percent in those with successful reperfusion and, among those with unsuccessful reperfusion, was much lower in patients with significant collaterals to the infarct-related artery (10 versus 58 percent in those without collaterals) [<a href="#rid54">54</a>]. This seems consistent with the findings (as noted above) of reduced infarction size in the presence of collaterals.</p><p></p><p class="headingAnchor" id="H7"><span class="h1">PROGNOSTIC SIGNIFICANCE</span></p><p class="headingAnchor" id="H141866190"><span class="h2">Acute myocardial infarction</span><span class="headingEndMark"> — </span>The absence of collateral circulation to the infarct-related artery may be an independent predictor of short-term morbidity and mortality in patients with an acute MI although association with long-term outcomes is less certain. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Short-term outcomes </strong>–<strong> </strong>In a report of 1059 patients undergoing primary percutaneous coronary intervention (PCI) for ST elevation MI (STEMI), increased collateral flow was associated with a lower incidence of Killip class ≥2 at presentation, less need for intraaortic balloon pumping after PCI, better myocardial blush grade after intervention, and smaller enzymatic infarct size [<a href="#rid55">55</a>]. In another series of 180 patients undergoing primary PCI for anterior STEMI, the in-hospital mortality rate was substantially lower in those with demonstrable collaterals as determined by angiography (8 versus 23 percent) [<a href="#rid56">56</a>]. This difference was primarily due to a lower frequency of cardiogenic shock among the patients with pre-existing collaterals.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Long-term outcomes </strong>– Studies are mixed as to whether collateral circulation has a long-term protective effect after an acute MI [<a href="#rid57">57-61</a>]. A smaller study with longer follow-up has shown benefit. Among 227 patients with STEMI (median follow up 797 days), the presence of extensive coronary collateral flow before primary PCI was associated with a significantly lower mortality (4.4 versus 13.8 percent) [<a href="#rid60">60</a>]. Similarly, a retrospective study of 3340 patients with STEMI treated with PCI found that patients with Rentrop class 1 and 2 collaterals had better in-hospital and five-year survival as compared with those without collateral flow (class 0). Persons with class 3 collaterals in this study did not have lower mortality, perhaps because they had a worse overall clinical profile [<a href="#rid61">61</a>]. </p><p></p><p class="bulletIndent1">However, an analysis from the large ACUITY trial of 5412 patients with acute coronary syndrome had collateral circulation assessed by a core laboratory using the Rentrop score and did not show benefit of collateral circulation [<a href="#rid60">60</a>]. Patients with collateral circulation had no difference in one-year major adverse cardiac events (hazard ratio [HR] 0.94 95% CI, 0.76-1.16), mortality (HR 1.03 95% CI, 0.65-1.62), MI (HR 1.07 95% CI 0.83-1.38), and unplanned target vessel revascularization (HR 0.95 95% CI 0.71-1.28) [<a href="#rid60">60</a>]. Furthermore, among patients with collateral circulation who underwent PCI, the risk of unplanned target vessel revascularization was increased (HR 2.74 95% CI 1.48-5.10). </p><p></p><p class="bulletIndent1">Longer-term outcome studies with core laboratory collateral flow measurements are needed. </p><p></p><p class="headingAnchor" id="H902874712"><span class="h2">Chronic coronary syndrome</span><span class="headingEndMark"> — </span>Patients with chronic coronary syndrome may have more favorable outcomes if they have collateral circulation. In a prior investigation, 845 patients (of whom 739 had chronic coronary syndrome and 106 patients had no obstructive coronary artery disease) underwent quantitative, coronary pressure-derived collateral measurements and were followed for a mean of five years [<a href="#rid62">62</a>]. Persons with a high collateral flow index, compared with those with a low index, had significantly higher cumulative rates of 10-year survival (88 versus 71 percent) and survival free of cardiac death (97 versus 89 percent). </p><p>The mechanism for impaired collateral formation in diabetics was evaluated in a series of 16 diabetics and 14 healthy volunteers [<a href="#rid63">63</a>]. The cellular response of monocytes to VEGF-A, an important step during collateral formation due to regional myocardial ischemia, was attenuated in the diabetic patients. The expression of vascular endothelial growth factor (VEGF) and hypoxia inducible factor (HIF-1alpha), a transcriptional activator of VEGF, was measured in ventricular biopsy specimens from patients undergoing coronary bypass surgery. Patients without diabetes had statistically significantly higher levels of VEGF and HIF-1alpha than diabetic patients, suggesting reduced expression of these angiogenesis factors [<a href="#rid64">64</a>].</p><p class="headingAnchor" id="H9"><span class="h1">THERAPEUTIC POTENTIAL</span><span class="headingEndMark"> — </span>Attention has been directed toward therapies that might augment the natural supply of collaterals through myocardial neovascularization. This topic is discussed in detail separately (see  <a class="medical medical_review" href="/z/d/html/1537.html" rel="external">"Therapeutic angiogenesis for management of refractory angina"</a>). At present, there are no specific pharmacologic therapies that are approved for augmenting collateral flow, although there is some evidence supporting exercise training:</p><p class="bulletIndent1"><span class="glyph">●</span>Serotonin receptor antagonists may ultimately be shown to be useful given that serotonin can reduce coronary artery collateral flow by vasoconstriction, possibly via platelet activation [<a href="#rid65">65</a>]. (See  <a class="medical medical_review" href="/z/d/html/1498.html" rel="external">"The role of platelets in coronary heart disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Angiotensin converting enzyme (ACE) inhibitors improve the endothelial dysfunction seen in atherosclerosis, suggesting that they may have a role in angiogenesis [<a href="#rid66">66</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There is no strong evidence supporting the angiogenic potential of statin therapy [<a href="#rid67">67</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Exercise training has been proposed as a means to stimulate collateral vessel formation. A prospective trial that assigned 60 subjects with clinically stable, hemodynamically significant coronary stenosis randomized participants to moderate- or high-intensity supervised exercise training for 10 hours per week over four weeks versus usual care [<a href="#rid32">32</a>]. Moderate- and high-intensity training led to 41.3 and 39.4 percent increases, respectively, in coronary collateral flow index (CFI), whereas CFI in the control group remained unchanged. Recruitment of preexisting collateral vessels was proposed as a potential mechanism underlying these observations. </p><p></p><p class="headingAnchor" id="H14"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Anastomotic channels known as collateral vessels can develop in the heart as an adaptation to ischemia. They serve as conduits that bridge severe stenoses or connect a territory supplied by one epicardial coronary artery with that of another. They are diagnosed by standard coronary angiographic observation. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Two classes of collateral vessels have been recognized: capillary size collaterals, in which smooth muscle cells are absent, may be observed throughout the myocardium, although they have a predilection for the subendocardium; and larger, muscular collaterals, which develop from pre-existing arterioles, are typically located epicardially. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Coronary collaterals can provide substantial blood flow to resting myocardium, but are generally insufficient during increased demand (exercise). (See <a class="local">'Physiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Collaterals may: reduce infarct size after myocardial infarction (MI); reduce post-MI complications such as rupture of a papillary muscle, myocardial free wall, or interventricular septum; and reduce aneurysmal dilatation. (See <a class="local">'Clinical significance'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The absence of collateral circulation to the infarct-related artery may be an independent predictor of mortality in patients with an acute MI, although evidence may be mixed. (See <a class="local">'Prognostic significance'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with diabetes have less well-developed collateral vessels. (See <a class="local">'Role of diabetes'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Fujita M, Sasayama S, Ohno A, et al. Importance of angina for development of collateral circulation. Br Heart J 1987; 57:139.</a></li><li><a class="nounderline abstract_t">Tayebjee MH, Lip GY, MacFadyen RJ. Collateralization and the response to obstruction of epicardial coronary arteries. QJM 2004; 97:259.</a></li><li><a class="nounderline abstract_t">Levin DC. Pathways and functional significance of the coronary collateral circulation. Circulation 1974; 50:831.</a></li><li><a class="nounderline abstract_t">Werner GS, Ferrari M, Betge S, et al. Collateral function in chronic total coronary occlusions is related to regional myocardial function and duration of occlusion. Circulation 2001; 104:2784.</a></li><li><a class="nounderline abstract_t">Schaper W. Collateral vessel growth in the human heart. Role of fibroblast growth factor-2. Circulation 1996; 94:600.</a></li><li><a class="nounderline abstract_t">Wustmann K, Zbinden S, Windecker S, et al. Is there functional collateral flow during vascular occlusion in angiographically normal coronary arteries? Circulation 2003; 107:2213.</a></li><li><a class="nounderline abstract_t">Piek JJ, van Liebergen RA, Koch KT, et al. Clinical, angiographic and hemodynamic predictors of recruitable collateral flow assessed during balloon angioplasty coronary occlusion. J Am Coll Cardiol 1997; 29:275.</a></li><li><a class="nounderline abstract_t">Senti S, Fleisch M, Billinger M, et al. Long-term physical exercise and quantitatively assessed human coronary collateral circulation. J Am Coll Cardiol 1998; 32:49.</a></li><li><a class="nounderline abstract_t">Pohl T, Seiler C, Billinger M, et al. Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol 2001; 38:1872.</a></li><li><a class="nounderline abstract_t">Kurotobi T, Sato H, Kinjo K, et al. Reduced collateral circulation to the infarct-related artery in elderly patients with acute myocardial infarction. J Am Coll Cardiol 2004; 44:28.</a></li><li><a class="nounderline abstract_t">Abaci A, Oğuzhan A, Kahraman S, et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999; 99:2239.</a></li><li><a class="nounderline abstract_t">Yang ZK, Shen Y, Dai Y, et al. Impact of coronary collateralization on long-term clinical outcomes in type 2 diabetic patients after successful recanalization of chronic total occlusion. Cardiovasc Diabetol 2020; 19:59.</a></li><li><a class="nounderline abstract_t">Fujita M, Ikemoto M, Kishishita M, et al. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation 1996; 94:610.</a></li><li><a class="nounderline abstract_t">Shweiki D, Itin A, Neufeld G, et al. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 1993; 91:2235.</a></li><li><a class="nounderline abstract_t">Schirmer SH, van Royen N, Moerland PD, et al. Local cytokine concentrations and oxygen pressure are related to maturation of the collateral circulation in humans. J Am Coll Cardiol 2009; 53:2141.</a></li><li><a class="nounderline abstract_t">Millard RW, Wang Y. Milieu intérieur: the search for myocardial arteriogenic signals. J Am Coll Cardiol 2009; 53:2148.</a></li><li><a class="nounderline abstract_t">Fleisch M, Billinger M, Eberli FR, et al. Physiologically assessed coronary collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease. Circulation 1999; 100:1945.</a></li><li><a class="nounderline abstract_t">Hojo Y, Ikeda U, Zhu Y, et al. Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J Am Coll Cardiol 2000; 35:968.</a></li><li><a class="nounderline abstract_t">Takeshita S, Isshiki T, Ochiai M, et al. Endothelium-dependent relaxation of collateral microvessels after intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia. Circulation 1998; 98:1261.</a></li><li><a class="nounderline abstract_t">Matsunaga T, Warltier DC, Weihrauch DW, et al. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 2000; 102:3098.</a></li><li><a class="nounderline abstract_t">Foreman BW, Dai XZ, Bache RJ. Vasoconstriction of canine coronary collateral vessels with vasopressin limits blood flow to collateral-dependent myocardium during exercise. Circ Res 1991; 69:657.</a></li><li><a class="nounderline abstract_t">Bache RJ, Schwartz JS. Myocardial blood flow during exercise after gradual coronary occlusion in the dog. Am J Physiol 1983; 245:H131.</a></li><li><a class="nounderline abstract_t">Sambuceti G, Parodi O, Giorgetti A, et al. Microvascular dysfunction in collateral-dependent myocardium. J Am Coll Cardiol 1995; 26:615.</a></li><li><a class="nounderline abstract_t">Frank MW, Harris KR, Ahlin KA, Klocke FJ. Endothelium-derived relaxing factor (nitric oxide) has a tonic vasodilating action on coronary collateral vessels. J Am Coll Cardiol 1996; 27:658.</a></li><li><a class="nounderline abstract_t">Feldman RD, Christy JP, Paul ST, Harrison DG. Beta-adrenergic receptors on canine coronary collateral vessels: characterization and function. Am J Physiol 1989; 257:H1634.</a></li><li><a class="nounderline abstract_t">Harrison DG, Chilian WM, Marcus ML. Absence of functioning alpha-adrenergic receptors in mature canine coronary collaterals. Circ Res 1986; 59:133.</a></li><li><a class="nounderline abstract_t">Traverse JH, Altman JD, Kinn J, et al. Effect of beta-adrenergic receptor blockade on blood flow to collateral-dependent myocardium during exercise. Circulation 1995; 91:1560.</a></li><li><a class="nounderline abstract_t">Traverse JH, Kinn JW, Klassen C, et al. Nitric oxide inhibition impairs blood flow during exercise in hearts with a collateral-dependent myocardial region. J Am Coll Cardiol 1998; 31:67.</a></li><li><a class="nounderline abstract_t">Kinn JW, Bache RJ. Effect of platelet activation on coronary collateral blood flow. Circulation 1998; 98:1431.</a></li><li><a class="nounderline abstract_t">Werner GS, Emig U, Mutschke O, et al. Regression of collateral function after recanalization of chronic total coronary occlusions: a serial assessment by intracoronary pressure and Doppler recordings. Circulation 2003; 108:2877.</a></li><li><a class="nounderline abstract_t">Lee JH, Kim CY, Kim N, et al. Coronary Collaterals Function and Clinical Outcome Between Patients With Acute and Chronic Total Occlusion. JACC Cardiovasc Interv 2017; 10:585.</a></li><li><a class="nounderline abstract_t">Möbius-Winkler S, Uhlemann M, Adams V, et al. Coronary Collateral Growth Induced by Physical Exercise: Results of the Impact of Intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable Coronary Artery Disease (EXCITE) Trial. Circulation 2016; 133:1438.</a></li><li><a class="nounderline abstract_t">Gensini GG, Bruto da Costa BC. The coronary collateral circulation in living man. Am J Cardiol 1969; 24:393.</a></li><li><a class="nounderline abstract_t">Rockstroh J, Brown BG. Coronary collateral size, flow capacity, and growth: estimates from the angiogram in patients with obstructive coronary disease. Circulation 2002; 105:168.</a></li><li><a class="nounderline abstract_t">Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5:587.</a></li><li><a class="nounderline abstract_t">Seiler C, Fleisch M, Garachemani A, Meier B. Coronary collateral quantitation in patients with coronary artery disease using intravascular flow velocity or pressure measurements. J Am Coll Cardiol 1998; 32:1272.</a></li><li><a class="nounderline abstract_t">Billinger M, Raeber L, Seiler C, et al. Coronary collateral perfusion in patients with coronary artery disease: effect of metoprolol. Eur Heart J 2004; 25:565.</a></li><li><a class="nounderline abstract_t">Sezer M, Nisanci Y, Umman B, et al. Pressure-derived collateral flow index: a strong predictor of late left ventricular remodeling after thrombolysis for acute myocardial infarction. Coron Artery Dis 2006; 17:139.</a></li><li><a class="nounderline abstract_t">Mills JD, Fischer D, Villanueva FS. Coronary collateral development during chronic ischemia: serial assessment using harmonic myocardial contrast echocardiography. J Am Coll Cardiol 2000; 36:618.</a></li><li><a class="nounderline abstract_t">Vernon SM, Camarano G, Kaul S, et al. Myocardial contrast echocardiography demonstrates that collateral flow can preserve myocardial function beyond a chronically occluded coronary artery. Am J Cardiol 1996; 78:958.</a></li><li><a class="nounderline abstract_t">Sabia PJ, Powers ER, Ragosta M, et al. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 1992; 327:1825.</a></li><li><a class="nounderline abstract_t">Christian TF, O'Connor MK, Schwartz RS, et al. Technetium-99m MIBI to assess coronary collateral flow during acute myocardial infarction in two closed-chest animal models. J Nucl Med 1997; 38:1840.</a></li><li><a class="nounderline abstract_t">Matsuo H, Watanabe S, Kadosaki T, et al. Validation of collateral fractional flow reserve by myocardial perfusion imaging. Circulation 2002; 105:1060.</a></li><li><a class="nounderline abstract_t">Pearlman JD, Laham RJ, Simons M, et al. Extent of myocardial collateralization: determination with three-dimensional elastic-subtraction spiral CT. Acad Radiol 1997; 4:680.</a></li><li><a class="nounderline abstract_t">Jerosch-Herold M, Wilke N. MR first pass imaging: quantitative assessment of transmural perfusion and collateral flow. Int J Card Imaging 1997; 13:205.</a></li><li><a class="nounderline abstract_t">Akutsu Y, Hara T, Michihata T, et al. Functional role of coronary collaterals with exercise in infarct-related myocardium. Int J Cardiol 1995; 51:47.</a></li><li><a class="nounderline abstract_t">Sand NP, Rehling M, Bagger JP, et al. Functional significance of recruitable collaterals during temporary coronary occlusion evaluated by 99mTc-sestamibi single-photon emission computerized tomography. J Am Coll Cardiol 2000; 35:624.</a></li><li><a class="nounderline abstract_t">Cheirif J, Narkiewicz-Jodko JB, Hawkins HK, et al. Myocardial contrast echocardiography: relation of collateral perfusion to extent of injury and severity of contractile dysfunction in a canine model of coronary thrombosis and reperfusion. J Am Coll Cardiol 1995; 26:537.</a></li><li><a class="nounderline abstract_t">Habib GB, Heibig J, Forman SA, et al. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation 1991; 83:739.</a></li><li><a class="nounderline abstract_t">Blanke H, Cohen M, Karsch KR, et al. Prevalence and significance of residual flow to the infarct zone during the acute phase of myocardial infarction. J Am Coll Cardiol 1985; 5:827.</a></li><li><a class="nounderline abstract_t">Nicolau JC, Pinto MA, Nogueira PR, et al. The role of antegrade and collateral flow in relation to left ventricular function post-thrombolysis. Int J Cardiol 1997; 61:47.</a></li><li><a class="nounderline abstract_t">Lee CW, Park SW, Cho GY, et al. Pressure-derived fractional collateral blood flow: a primary determinant of left ventricular recovery after reperfused acute myocardial infarction. J Am Coll Cardiol 2000; 35:949.</a></li><li><a class="nounderline abstract_t">Rentrop KP, Feit F, Sherman W, et al. Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: primary end point findings of the Second Mount Sinai-New York University Reperfusion Trial. J Am Coll Cardiol 1989; 14:58.</a></li><li><a class="nounderline abstract_t">Hirai T, Fujita M, Nakajima H, et al. Importance of collateral circulation for prevention of left ventricular aneurysm formation in acute myocardial infarction. Circulation 1989; 79:791.</a></li><li><a class="nounderline abstract_t">Elsman P, van 't Hof AW, de Boer MJ, et al. Role of collateral circulation in the acute phase of ST-segment-elevation myocardial infarction treated with primary coronary intervention. Eur Heart J 2004; 25:854.</a></li><li><a class="nounderline abstract_t">Pérez-Castellano N, García EJ, Abeytua M, et al. Influence of collateral circulation on in-hospital death from anterior acute myocardial infarction. J Am Coll Cardiol 1998; 31:512.</a></li><li><a class="nounderline abstract_t">Nicolau JC, Nogueira PR, Pinto MA, et al. Early infarct artery collateral flow does not improve long-term survival following thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1999; 83:21.</a></li><li><a class="nounderline abstract_t">Antoniucci D, Valenti R, Moschi G, et al. Relation between preintervention angiographic evidence of coronary collateral circulation and clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction. Am J Cardiol 2002; 89:121.</a></li><li><a class="nounderline abstract_t">Desch S, de Waha S, Eitel I, et al. Effect of coronary collaterals on long-term prognosis in patients undergoing primary angioplasty for acute ST-elevation myocardial infarction. Am J Cardiol 2010; 106:605.</a></li><li><a class="nounderline abstract_t">Meier P, Lansky AJ, Fahy M, et al. The impact of the coronary collateral circulation on outcomes in patients with acute coronary syndromes: results from the ACUITY trial. Heart 2014; 100:647.</a></li><li><a class="nounderline abstract_t">Hara M, Sakata Y, Nakatani D, et al. Impact of coronary collaterals on in-hospital and 5-year mortality after ST-elevation myocardial infarction in the contemporary percutaneous coronary intervention era: a prospective observational study. BMJ Open 2016; 6:e011105.</a></li><li><a class="nounderline abstract_t">Meier P, Gloekler S, Zbinden R, et al. Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation 2007; 116:975.</a></li><li><a class="nounderline abstract_t">Waltenberger J, Lange J, Kranz A. Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals. Circulation 2000; 102:185.</a></li><li><a class="nounderline abstract_t">Marfella R, Esposito K, Nappo F, et al. Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes. Diabetes 2004; 53:2383.</a></li><li><a class="nounderline abstract_t">Tanaka T, Fujita M, Nakae I, et al. Improvement of exercise capacity by sarpogrelate as a result of augmented collateral circulation in patients with effort angina. J Am Coll Cardiol 1998; 32:1982.</a></li><li><a class="nounderline abstract_t">Fabre JE, Rivard A, Magner M, et al. Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo. Circulation 1999; 99:3043.</a></li><li><a class="nounderline abstract_t">Zbinden S, Brunner N, Wustmann K, et al. Effect of statin treatment on coronary collateral flow in patients with coronary artery disease. Heart 2004; 90:448.</a></li></ol></div><div id="topicVersionRevision">Topic 1523 Version 15.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3814448" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Importance of angina for development of collateral circulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15100419" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Collateralization and the response to obstruction of epicardial coronary arteries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4425386" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Pathways and functional significance of the coronary collateral circulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11733395" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Collateral function in chronic total coronary occlusions is related to regional myocardial function and duration of occlusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8772674" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Collateral vessel growth in the human heart. Role of fibroblast growth factor-2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12707241" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Is there functional collateral flow during vascular occlusion in angiographically normal coronary arteries?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9014978" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Clinical, angiographic and hemodynamic predictors of recruitable collateral flow assessed during balloon angioplasty coronary occlusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9669248" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Long-term physical exercise and quantitatively assessed human coronary collateral circulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11738287" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15234401" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Reduced collateral circulation to the infarct-related artery in elderly patients with acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10226087" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Effect of diabetes mellitus on formation of coronary collateral vessels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32393276" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Impact of coronary collateralization on long-term clinical outcomes in type 2 diabetic patients after successful recanalization of chronic total occlusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8772678" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7683699" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19497439" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Local cytokine concentrations and oxygen pressure are related to maturation of the collateral circulation in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19497440" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Milieu intérieur: the search for myocardial arteriogenic signals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10556219" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Physiologically assessed coronary collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10732896" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Expression of vascular endothelial growth factor in patients with acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9751672" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Endothelium-dependent relaxation of collateral microvessels after intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11120701" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1873862" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Vasoconstriction of canine coronary collateral vessels with vasopressin limits blood flow to collateral-dependent myocardium during exercise.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6869554" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Myocardial blood flow during exercise after gradual coronary occlusion in the dog.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7642850" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Microvascular dysfunction in collateral-dependent myocardium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8606278" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Endothelium-derived relaxing factor (nitric oxide) has a tonic vasodilating action on coronary collateral vessels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2574008" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Beta-adrenergic receptors on canine coronary collateral vessels: characterization and function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2874899" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Absence of functioning alpha-adrenergic receptors in mature canine coronary collaterals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7867199" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Effect of beta-adrenergic receptor blockade on blood flow to collateral-dependent myocardium during exercise.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9426020" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Nitric oxide inhibition impairs blood flow during exercise in hearts with a collateral-dependent myocardial region.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9760298" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Effect of platelet activation on coronary collateral blood flow.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14623811" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Regression of collateral function after recanalization of chronic total coronary occlusions: a serial assessment by intracoronary pressure and Doppler recordings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28335895" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Coronary Collaterals Function and Clinical Outcome Between Patients With Acute and Chronic Total Occlusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26979085" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Coronary Collateral Growth Induced by Physical Exercise: Results of the Impact of Intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable Coronary Artery Disease (EXCITE) Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5805200" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The coronary collateral circulation in living man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11790696" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Coronary collateral size, flow capacity, and growth: estimates from the angiogram in patients with obstructive coronary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3156171" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9809936" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Coronary collateral quantitation in patients with coronary artery disease using intravascular flow velocity or pressure measurements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15120053" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Coronary collateral perfusion in patients with coronary artery disease: effect of metoprolol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16474232" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Pressure-derived collateral flow index: a strong predictor of late left ventricular remodeling after thrombolysis for acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10933379" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Coronary collateral development during chronic ischemia: serial assessment using harmonic myocardial contrast echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8888677" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Myocardial contrast echocardiography demonstrates that collateral flow can preserve myocardial function beyond a chronically occluded coronary artery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1448120" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9430456" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Technetium-99m MIBI to assess coronary collateral flow during acute myocardial infarction in two closed-chest animal models.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11877355" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Validation of collateral fractional flow reserve by myocardial perfusion imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9344290" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Extent of myocardial collateralization: determination with three-dimensional elastic-subtraction spiral CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9220283" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : MR first pass imaging: quantitative assessment of transmural perfusion and collateral flow.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8522396" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Functional role of coronary collaterals with exercise in infarct-related myocardium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10716464" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Functional significance of recruitable collaterals during temporary coronary occlusion evaluated by 99mTc-sestamibi single-photon emission computerized tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7608461" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Myocardial contrast echocardiography: relation of collateral perfusion to extent of injury and severity of contractile dysfunction in a canine model of coronary thrombosis and reperfusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1900223" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3973287" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Prevalence and significance of residual flow to the infarct zone during the acute phase of myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9292332" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : The role of antegrade and collateral flow in relation to left ventricular function post-thrombolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10732893" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Pressure-derived fractional collateral blood flow: a primary determinant of left ventricular recovery after reperfused acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2500472" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: primary end point findings of the Second Mount Sinai-New York University Reperfusion Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2924412" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Importance of collateral circulation for prevention of left ventricular aneurysm formation in acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15140533" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Role of collateral circulation in the acute phase of ST-segment-elevation myocardial infarction treated with primary coronary intervention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9502628" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Influence of collateral circulation on in-hospital death from anterior acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10073779" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Early infarct artery collateral flow does not improve long-term survival following thrombolytic therapy for acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11792328" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Relation between preintervention angiographic evidence of coronary collateral circulation and clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20723632" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Effect of coronary collaterals on long-term prognosis in patients undergoing primary angioplasty for acute ST-elevation myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24310521" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : The impact of the coronary collateral circulation on outcomes in patients with acute coronary syndromes: results from the ACUITY trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27412101" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Impact of coronary collaterals on in-hospital and 5-year mortality after ST-elevation myocardial infarction in the contemporary percutaneous coronary intervention era: a prospective observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17679611" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10889129" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15331549" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9857882" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Improvement of exercise capacity by sarpogrelate as a result of augmented collateral circulation in patients with effort angina.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10368123" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15020529" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Effect of statin treatment on coronary collateral flow in patients with coronary artery disease.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
